New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System
Jahanzaib Khwaja(University College Hospital), Ashutosh Wechalekar(University College Hospital), Valeria Di Simone(University of Pavia), Efstathios Kastritis(National and Kapodistrian University of Athens), Amy A. Kirkwood(Cancer Research UK), Helen J. Lachmann(Royal Free London NHS Foundation Trust), Roberta Mussinelli, Shaji Kumar(Mayo Clinic), Lucia Venneri(MACOM (United States)), Oliver Cohen(University Hospitals Birmingham NHS Foundation Trust), Monique C. Minnema(University Medical Center Utrecht), Marianna Fontana(Amyloidosis Foundation), Αlexandros Briasoulis(University of Iowa), Julian D. Gillmore(Alnylam Pharmaceuticals (United States)), Carol Whelan(The Royal Free Hospital), Foteini Theodorakakou(National and Kapodistrian University of Athens), Sriram Ravichandran(The Royal Free Hospital), Κimon Stamatelopoulos(National and Kapodistrian University of Athens), Eli Muchtar(Mayo Clinic), Marish I.F.J. Oerlemans(University Medical Center Utrecht), Giovanni Palladini(University of Pavia), Paolo Milani(University of Pavia), Rahel Schwotzer(University Hospital of Zurich), Binoy Yohannan(The University of Texas Health Science Center at Houston), Flores Weverling(Utrecht University), Ιoannis Petropoulos(National and Kapodistrian University of Athens), Angela Dispenzieri(Mayo Clinic), Shameem Mahmood(The Royal Free Hospital), Morie A. Gertz(Medical University of South Carolina)
Cited by 8
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k